Hong Kong · Medical and donor conditions

Editorial image of clinical consultation and laboratory microscope
Editorial illustration; not a photograph of an identified clinic or approval.

Hong Kong surrogacy: medical requirements and donor-gamete restrictions

The decision in one page

Hong Kong does not treat surrogacy as ordinary donor-assisted IVF. For a surrogacy arrangement under Hong Kong's Human Reproductive Technology Ordinance (Cap. 561), the gametes must come from the married commissioning couple, and a licensed centre must separately assess the clinical indication and the proposed surrogate. A donor egg, donor sperm or donated embryo does not become lawful for this arrangement simply because it is medically recommended. First identify whose egg and sperm would be used, whether the intended mother can carry a pregnancy, and whether the clinic actually holds the appropriate authorisation. This is a Hong Kong treatment-law analysis, not approval of a programme abroad.

Which rules have which force?

The binding starting points are Cap. 561, notably sections 13–15 and 17–18, and, for the later parentage question, Cap. 429. The Council on Human Reproductive Technology (CHRT) also maintains its Code of Practice. Its current published edition took effect on 1 December 2025. The Code governs clinical and ethical practice for licensed services; a breach of the Code is not automatically a separate offence, but compliance is considered in licence decisions and another legal or professional duty may independently be breached. A clinic's internal protocol can be more cautious still. Always ask whether a proposed condition comes from statute, CHRT Code, licence terms or the clinic itself.

Donor gametes: the non-negotiable distinction

Section 14 of Cap. 561 bars the use in a surrogacy arrangement of gametes other than those of the two people who are parties to the commissioning marriage. Accordingly, substituting donor sperm for the husband's sperm, donor eggs for the wife's eggs, or a donated embryo is not a route around a participant's infertility for a Hong Kong surrogacy procedure. This is different from donor treatment where the woman receiving treatment intends to carry the pregnancy herself. The fact that an egg or embryo was lawfully donated, stored or imported does not override the surrogacy-specific restriction. Request traceable laboratory records of each gamete's source before any embryo is created or transferred.

Clinical indication for the commissioning wife

Paragraph 12.2 of the CHRT Code permits a reproductive technology procedure pursuant to surrogacy only where the wife in the commissioning marriage cannot carry a pregnancy to term and no other treatment option is practicable for her. This is a medical threshold in the licensing framework, not a general permission to choose surrogacy for convenience, scheduling, occupation or preference. Obtain a specialist's signed clinical assessment explaining the diagnosis, prognosis, previous treatments where relevant, and why alternatives are not practicable. A finding of infertility alone does not necessarily establish inability to carry a pregnancy to term. The clinician must address that specific question rather than assume it.

Independent assessment of the proposed surrogate

The Code's paragraph 12.3 calls for assessment by a registered medical practitioner who is not responsible for the surrogacy reproductive procedure. The assessment considers the woman's marital status, pregnancy history and physical and mental fitness to carry a child. Someone with a higher risk of pregnancy complications should not be accepted as a surrogate. Paragraph 12.4 states that a woman under 21 shall not act as a surrogate mother. These are Code standards relevant to licensed clinical practice; they should not be misreported as a general statutory age limit for all women undergoing IVF. Ask for a documented independent medical opinion and the clinic's risk assessment before selection.

Consent and multidisciplinary counselling

Under paragraphs 12.5–12.7 of the Code, the surrogate's consent and, if she is married, her husband's consent are relevant. The licensed centre must arrange counselling by a multidisciplinary team for the married commissioning couple, the surrogate and her husband if applicable. The Code describes two non-attending registered doctors who both recommended the arrangement and explain its medical implications, a family-law adviser explaining legal implications, a medically informed social worker, and a clinical psychologist when appropriate. Written informed consent for each treatment cycle is also addressed by paragraph 6.1: before active treatment, but not earlier than six months before that cycle. Consent documents are evidence of an informed decision; they do not make an otherwise prohibited donor arrangement permissible.

Welfare and practical suitability

Paragraph 12.8 makes the child's welfare paramount to the clinical assessment of the surrogate and commissioning couple. The centre should consider health and family histories, social and mental wellbeing, parenting commitment, a stable home, the ability to meet a child's needs, age-related future care, possible disability or multiple births, risk of harm and the attitudes of other family members. Paragraph 12.9 calls for properly recorded recommendations and counselling reasons. None of these assessments can override the statutory rule on whose gametes may be used. Conversely, meeting the genetic requirement does not compel clinicians to proceed where the pregnancy risks or welfare assessment are unacceptable.

Donor screening rules do not create a surrogacy exception

The CHRT Code's general donor-treatment chapter contains infectious-disease and hereditary-disorder screening requirements, including assessment of the donor's personal and family history. Paragraph 4.10 ordinarily places egg donors below 35 and sperm donors below 55, with described room for justified exceptions; paragraph 4.11 advises against collecting gametes from people under 18, apart from limited own/spousal-treatment situations. These figures concern donors in the wider assisted-reproduction system, not permission to use third-party gametes for Hong Kong surrogacy. Do not confuse a donor's eligibility with a surrogate's separate age-21 standard, or a clinic's internal preferred age range with a universal statute.

Screening and consent for assisted reproduction

In donor treatment outside the surrogacy branch, the Code requires infectious-disease screening and consideration of hereditary risks. Paragraph 4.8 discusses a further HIV antibody test six months after donation unless specified fresh egg or embryo circumstances apply, and does not permit fresh donor sperm. The Code also requires valid written consent to reproductive procedures and storage. These are clinical safety and records obligations, not a promise of a safe pregnancy or a blanket legal clearance for any donor source. For the proposed Hong Kong surrogacy case, the separate questions are whether the spouses' own gametes are usable, what screening the centre requires, and whether any medical contraindication remains.

Embryo testing and sex selection

Pre-implantation testing may be discussed for a documented medical reason, but testing does not change the identity of an embryo's genetic contributors. Section 15(3) of Cap. 561 generally prohibits reproductive-technology sex selection; its limited exception concerns preventing a sex-linked genetic disease specified in Schedule 2, supported in writing by at least two registered medical practitioners who consider the disease sufficiently severe. The Code's Chapter XIII treats sex selection as a last resort and distinguishes it from ordinary genetic screening. Choosing the preferred sex of a child for family balancing is not allowed. Obtain a written explanation of any proposed test and its legal indication before agreeing to it.

Stored or imported embryos do not remove the restriction

A stored embryo may raise separate issues of consent, identification, custody, quality control, transport and lawful import or export. Chapter IX of the Code addresses local transfers and imports of gametes or embryos, and Chapter X covers storage and disposal. None of those operational processes changes section 14's surrogacy-specific rule. If the spouses previously created embryos using one donor gamete, those embryos cannot simply be repurposed for Hong Kong surrogacy. Seek written confirmation of the gametes' origin, the embryo's storage history and the exact purpose of any proposed transfer. Overseas storage or a foreign clinic's willingness to act is not a Hong Kong authorisation.

Provider licence and real service availability

Section 13 requires a CHRT licence for the specific reproductive activity; an ordinary IVF licence does not authorise surrogacy. The CHRT treatment-service appendix marks no centre as offering ‘surrogacy arrangement’. The document displays different reference dates on its centre list (1 October 2026) and graphical service appendix (1 July 2026). Separately, the Hong Kong Inland Revenue Department's published FAQ states that no licensed centre is currently authorised to provide surrogacy arrangements. Thus a couple can meet the legal and medical criteria in principle yet have no authorised provider in Hong Kong. This is a time-sensitive service-status finding, not a permanent statutory ban. Before paying, creating embryos or transporting gametes, obtain dated written confirmation directly from CHRT of the proposed centre's precise licence and authorised treatment services; do not rely on a general IVF licence or marketing claim.

Decision matrix: what changes the result?

A married couple providing both their own gametes clears the specific donor-source prohibition but must still meet clinical, safeguarding and licensing requirements. A donor egg, donor sperm or donated embryo fails the section 14 surrogacy condition in Hong Kong. The wife's inability to carry a pregnancy to term, with no practicable alternative, must be clinically evidenced under Code paragraph 12.2. A surrogate younger than 21 or at increased pregnancy risk conflicts with Chapter XII standards. Even a fully documented proposal cannot be carried out by an unlicensed or unauthorised provider. These are cumulative checks, not interchangeable alternatives, and a favourable answer on one does not fix failure of another.

Documents to request before committing funds

Build one case file with: the commissioning couple's marriage evidence; certified identities and medical records; laboratory proof that egg and sperm belong to the two spouses; fertility assessments and the specialist's explanation why the wife cannot carry to term; independent surrogate medical and pregnancy-history assessment; counselling and informed-consent records, including the surrogate's husband's consent where applicable; screening and embryo/storage chain-of-custody documents; and written evidence of the clinic's specific licence authorisation. Ask which records are mandatory under the Code, which are statutory, and which additional documents the individual centre requires. The list is a preparation checklist, not a representation that presenting papers guarantees treatment.

Order of actions and response to a refusal

Before embryo creation or transfer, screen the proposed gamete sources against section 14 and obtain a medical opinion on the wife's condition. Then check the surrogate's independent risk assessment, counselling, consent and the precise treatment licence. Ask the centre for a written decision that distinguishes legal ineligibility, Code non-compliance, clinical contraindication and discretionary clinic policy. If refused, request the reasons and whether additional medical evidence, correction of records or a different licensed provider could lawfully address them. The Code says the reasons for an unsuitability finding should be recorded and explained, with counselling or referral as appropriate. A refusal cannot be cured by concealment or mislabelling donor gametes.

Limits: payments and parentage are separate questions

Medical eligibility alone does not validate a contract or establish parentage. Sections 17 and 18 of Cap. 561 address commercial surrogacy and unenforceable arrangements, while the Ordinance defines certain genuine medical or reproductive-treatment expense reimbursement outside its 'payment' definition. Whether a proposed transfer of money qualifies requires transaction-specific review; labels such as 'gift' or 'expenses' do not decide it. The CHRT explains that a commissioning couple ordinarily needs a court order under section 12 of the Parent and Child Ordinance within six months of birth for legal parentage. Those contract, court and cross-border questions require separate advice before treatment, not an assumption that DNA proves parenthood.

What to do with a borderline or overseas case

A person considering donor IVF without a surrogate should obtain advice under the general assisted-reproduction rules, because the section 14 surrogacy prohibition is not a universal ban on donors. A couple considering treatment abroad must separately verify the law of the treatment location, embryo-export conditions and later Hong Kong parentage and immigration effects; Hong Kong's domestic Code does not itself license foreign providers. For a difficult case, seek an independent Hong Kong reproductive-medicine opinion and family-law review using the actual diagnoses, gamete provenance, clinic licence and proposed payment schedule. Do not describe the project as legally cleared until the competent clinicians and legal professionals have checked the precise facts.

Official and primary regulatory sources

  1. CHRT: Frequently Asked Questions for Patients (S1)
  2. CHRT: Code of Practice on Reproductive Technology and Embryo Research, December 2025 (S2)
  3. Government answer: LCQ9 Surrogacy arrangements, 24 May 2023 (S3)
  4. CHRT: Frequently Asked Questions for Donors (S4)
  5. CHRT: Activities that Require a Licence (S5)
  6. CHRT: List of Licensed Centres – Treatment (S6)
  7. Hong Kong Inland Revenue Department: Assisted Reproductive Service Expenses, FAQ 21 (S7)

Obtain legal advice on the specific treatment and circumstances before relying on this information.

Last updated:

Author: Khachatrian Razmik, LL.M.

International surrogacy and parentage legal services — LEX SURROGACY by Lex Agency · Author profile · Editorial standards